Literature DB >> 1674633

More than half the sporadic cases of hemophilia A in Sweden are due to a recent mutation.

R Ljung1, S Kling, E Sjörin, I M Nilsson.   

Abstract

The aim of this study was to ascertain how many of the sporadic cases of severe Haemophilia A in Sweden are due to recent mutation, and establish its origin. DNA analysis was performed in 18 randomly selected families with a sporadic case of severe haemophilia A. Restriction fragment length polymorphism (RFLP) patterns were investigated, two intragenic (Bc1 I, Xba I/Kpn I) and two extragenic (DX 13, St 14) RFLP being used. In 10/18 families a haemophilia-linked gene was found to have derived from the healthy maternal grandfather; on the basis of clotting and immunological assay results, the odds were high (greater than 104:1) for maternal carriership in four of these 10 cases, and for maternal non-carriership in two, four being indeterminate. In 4/18 families a haemophilia-linked gene derived from the healthy maternal grandmother; according to clotting and immunological assay results, in two cases the odds were high for maternal non-carriership. In the remaining 4/18 families no conclusions could be drawn from the RFLP pattern as to the origin of mutation. We conclude that at least 55% of the sporadic cases of severe hemophilia A in Sweden are due to a recent mutation within the last two generations.

Entities:  

Mesh:

Year:  1991        PMID: 1674633     DOI: 10.1111/j.1651-2227.1991.tb11860.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  4 in total

1.  Genotyping of Intron Inversions and Point Mutations in Exon 14 of the FVIII Gene in Iranian Azeri Turkish Families with Hemophilia A.

Authors:  Mahmoud Shekari Khaniani; Abdollah Ebrahimi; Setareh Daraei; Sima Mansoori Derakhshan
Journal:  Indian J Hematol Blood Transfus       Date:  2016-06-27       Impact factor: 0.900

2.  Prominent Mutation of Intron 22 Inversion in Sporadic Hemophilia: Is It Worth the Antenatal Screening?

Authors:  Werasak Sasanakul; Ampaiwan Chuansumrit; Nongnuch Sirachainan; Praguywan Kadegasem
Journal:  Appl Clin Genet       Date:  2022-05-19

Review 3.  Treatment strategies in children with hemophilia.

Authors:  Pia Petrini
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

4.  Novel F8 and F9 gene variants from the PedNet hemophilia registry classified according to ACMG/AMP guidelines.

Authors:  Nadine G Andersson; Veerle Labarque; Anna Letelier; Maria Elisa Mancuso; Martina Bührlen; Kathelijn Fischer; Mutlu Kartal-Kaess; Minna Koskenvuo; Torben Mikkelsen; Rolf Ljung
Journal:  Hum Mutat       Date:  2020-10-14       Impact factor: 4.878

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.